ID   OCUG-1
AC   CVCL_3083
SY   OCUG1; Osaka City University Gallbladder-1
DR   BioSample; SAMN03471651
DR   Cell_Model_Passport; SIDM01842
DR   Cosmic; 2629295
DR   Cosmic; 2674062
DR   DepMap; ACH-001619
DR   GEO; GSM827176
DR   JCRB; JCRB0191
DR   LINCS_LDP; LCL-1800
DR   Progenetix; CVCL_3083
DR   Wikidata; Q54931819
RX   PubMed=20215515;
RX   PubMed=21533512;
RX   PubMed=32899426;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 47.1 hours (PubMed=21533512).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg267Trp (c.799C>T); ClinVar=VCV000141764; Zygosity=Heterozygous (DepMap).
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: Metastatic; Peritoneal effusion; UBERON=UBERON_0001268.
ST   Source(s): DepMap; JCRB
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 16,19
ST   D21S11: 28,29
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   D8S1179: 14,15
ST   FGA: 21,24
ST   Penta D: 9
ST   Penta E: 5,20
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 15,16 (JCRB)
ST   vWA: 16 (DepMap)
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 23
//
RX   PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458;
RA   Rothenberg S.M., Mohapatra G., Rivera M.N., Winokur D., Greninger P.,
RA   Nitta M., Sadow P.M., Sooriyakumar G., Brannigan B.W., Ulman M.J.,
RA   Perera R.M., Wang R., Tam A., Ma X.-J., Erlander M., Sgroi D.C.,
RA   Rocco J.W., Lingen M.W., Cohen E.E.W., Louis D.N., Settleman J.,
RA   Haber D.A.;
RT   "A genome-wide screen for microdeletions reveals disruption of
RT   polarity complex genes in diverse human cancers.";
RL   Cancer Res. 70:2158-2164(2010).
//
RX   PubMed=21533512; DOI=10.3892/ijo.10.6.1251;
RA   Yamada N., Chung Y.-S., Ohtani H., Ikeda T., Onoda N., Sawada T.,
RA   Nishiguchi Y., Hasuma T., Sowa M.;
RT   "Establishment and characterization of a new human gallbladder
RT   carcinoma cell line (OCUG-1) producing TA-4.";
RL   Int. J. Oncol. 10:1251-1255(1997).
//
RX   PubMed=32899426; DOI=10.3390/cancers12092510;
RA   Scherer D., Davila Lopez M., Goeppert B., Abrahamsson S.,
RA   Gonzalez Silos R., Nova I., Marcelain K., Roa J.C., Ibberson D.,
RA   Umu S.U., Rounge T.B., Roessler S., Lorenzo-Bermejo J.;
RT   "RNA sequencing of hepatobiliary cancer cell lines: data and
RT   applications to mutational and transcriptomic profiling.";
RL   Cancers (Basel) 12:2510.1-2510.14(2020).
//